JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors Miguel NogueiraLuis PuigTiago Torres Current Opinion 04 February 2020 Pages: 341 - 352
The Rise and Fall “ing” of the HDL Hypothesis Julien J. FeghalyArshag D. Mooradian Current Opinion 04 February 2020 Pages: 353 - 362
Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs Uazman AlamGordon SloanSolomon Tesfaye Review Article 10 February 2020 Pages: 363 - 384
Pharmacological Prevention of Postoperative Recurrence in Crohn’s Disease Lucine VuittonLaurent Peyrin-Biroulet Review Article 13 February 2020 Pages: 385 - 399
Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future Perspectives Juliette PalleAdrien RochandAziz Zaanan Review Article 19 February 2020 Pages: 401 - 415
Sodium Oligomannate: First Approval Yahiya Y. Syed AdisInsight Report 04 February 2020 Pages: 441 - 444
Correction to: Sodium Oligomannate: First Approval Yahiya Y. Syed Correction 24 February 2020 Pages: 445 - 446
Correction to: Pexidartinib: First Approval Yvette N. Lamb Correction Open access 28 February 2020 Pages: 447 - 447